BSX vs SYK
BSX and SYK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | SYKSTRYKER CORP |
|---|---|---|
| Market cap | $71.48B | $130.00B |
| P/E (TTM) | 20.0 | 35.1 |
| P/B | 2.87 | 11.08 |
| P/S | 3.6x | 5.2x |
| Dividend yield | — | 0.99% |
| Revenue | $21.00B(TTM) | $25.84B(TTM) |
| Revenue growth (YoY) | 19.9% | 11.2% |
| Net income | $3.67B(TTM) | $3.73B(TTM) |
| Earnings growth (YoY) | 56.7% | 8.5% |
| EPS, diluted | $2.47(TTM) | $9.65(TTM) |
| EBIT margin | 18.0% | 19.5% |
| ROE | 11.6% | 27.7% |
| ROIC | 10.0% | 15.1% |
| Piotroski F | 8/9 | 8/9 |
| 1y total return | -52.1% | -9.0% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BSX vs SYK
| Metric | BSX | SYK |
|---|---|---|
| End value | $25.2K | $35.0K |
| Total return | +152.1% | +250.2% |
| CAGR | +9.4% | +12.9% |
| Volatility | 27.4% | 26.5% |
| Sharpe | 0.32 | 0.45 |
| Sortino | 0.44 | 0.64 |
| Max drawdown | -60.6% | -43.8% |
Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.87% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)